Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Centrosome | 7 | 2023 | 209 | 1.600 |
Why?
|
Mitosis | 12 | 2023 | 1186 | 1.260 |
Why?
|
Micronuclei, Chromosome-Defective | 2 | 2020 | 38 | 0.870 |
Why?
|
Nuclear Envelope | 2 | 2020 | 162 | 0.810 |
Why?
|
Cell Nucleus | 3 | 2020 | 2881 | 0.540 |
Why?
|
Cell Division | 3 | 2015 | 4451 | 0.490 |
Why?
|
Dyneins | 1 | 2015 | 124 | 0.480 |
Why?
|
Myosins | 1 | 2015 | 404 | 0.440 |
Why?
|
beta Catenin | 1 | 2016 | 1042 | 0.380 |
Why?
|
Gene Amplification | 1 | 2016 | 1084 | 0.370 |
Why?
|
Microtubules | 9 | 2018 | 1071 | 0.330 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2871 | 0.320 |
Why?
|
Drosophila melanogaster | 4 | 2008 | 1710 | 0.300 |
Why?
|
Neoplasms | 7 | 2023 | 22140 | 0.300 |
Why?
|
Genomic Instability | 3 | 2020 | 709 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5300 | 0.250 |
Why?
|
Angiogenic Proteins | 1 | 2006 | 101 | 0.250 |
Why?
|
Gallic Acid | 1 | 2024 | 24 | 0.230 |
Why?
|
Chromosome Positioning | 1 | 2003 | 18 | 0.230 |
Why?
|
Chromatids | 1 | 2003 | 62 | 0.220 |
Why?
|
Microarray Analysis | 1 | 2006 | 748 | 0.210 |
Why?
|
Culture Media, Serum-Free | 1 | 2002 | 148 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2820 | 0.180 |
Why?
|
Chromosomes | 1 | 2004 | 578 | 0.180 |
Why?
|
Nerve Growth Factor | 1 | 2002 | 157 | 0.180 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4872 | 0.170 |
Why?
|
RNA, Small Interfering | 5 | 2018 | 3412 | 0.170 |
Why?
|
Inflammasomes | 1 | 2024 | 526 | 0.160 |
Why?
|
Microscopy, Fluorescence | 3 | 2016 | 2635 | 0.160 |
Why?
|
Molecular Motor Proteins | 3 | 2004 | 106 | 0.160 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 16952 | 0.150 |
Why?
|
Anaphase | 4 | 2010 | 114 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2020 | 348 | 0.140 |
Why?
|
Cell Death | 1 | 2002 | 1676 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 559 | 0.130 |
Why?
|
Tetraploidy | 1 | 2016 | 28 | 0.130 |
Why?
|
Cytoplasm | 1 | 2020 | 1498 | 0.130 |
Why?
|
Angiogenesis Inhibitors | 1 | 2006 | 2047 | 0.130 |
Why?
|
Thiazolidines | 1 | 2015 | 69 | 0.130 |
Why?
|
Neovascularization, Pathologic | 1 | 2006 | 2636 | 0.120 |
Why?
|
Drosophila Proteins | 4 | 2010 | 1696 | 0.120 |
Why?
|
Cell Cycle | 2 | 2016 | 2925 | 0.120 |
Why?
|
Cytokinesis | 1 | 2016 | 169 | 0.120 |
Why?
|
Microtubule-Organizing Center | 2 | 2010 | 25 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1812 | 0.110 |
Why?
|
DNA Damage | 2 | 2020 | 2442 | 0.110 |
Why?
|
Cell Cycle Proteins | 3 | 2010 | 3446 | 0.110 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2010 | 0.100 |
Why?
|
Animals | 15 | 2024 | 168079 | 0.100 |
Why?
|
HeLa Cells | 2 | 2015 | 3073 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 736 | 0.100 |
Why?
|
Cell Adhesion | 3 | 2009 | 3091 | 0.090 |
Why?
|
Gene Expression | 3 | 2016 | 7571 | 0.090 |
Why?
|
Interphase | 2 | 2008 | 227 | 0.080 |
Why?
|
Tubulin Modulators | 1 | 2010 | 107 | 0.080 |
Why?
|
Cell Survival | 2 | 2018 | 5778 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2548 | 0.080 |
Why?
|
Phosphoprotein Phosphatases | 2 | 2014 | 328 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 613 | 0.080 |
Why?
|
Drug Synergism | 2 | 2020 | 1756 | 0.080 |
Why?
|
Proteins | 2 | 2020 | 5993 | 0.080 |
Why?
|
Meiosis | 1 | 2010 | 327 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3044 | 0.080 |
Why?
|
Phosphorylation | 2 | 2016 | 8300 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 2 | 2010 | 1075 | 0.080 |
Why?
|
Cell Polarity | 2 | 2008 | 638 | 0.070 |
Why?
|
Cell Shape | 1 | 2008 | 370 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2816 | 0.070 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2006 | 42 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6819 | 0.070 |
Why?
|
Metaphase | 2 | 2003 | 145 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1967 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2006 | 151 | 0.060 |
Why?
|
Endostatins | 1 | 2006 | 168 | 0.060 |
Why?
|
Protein Phosphatase 1 | 1 | 2006 | 134 | 0.060 |
Why?
|
Ploidies | 2 | 2020 | 285 | 0.060 |
Why?
|
Sesquiterpenes | 1 | 2006 | 176 | 0.060 |
Why?
|
Embryo, Nonmammalian | 2 | 2010 | 904 | 0.060 |
Why?
|
Drosophila | 2 | 2010 | 1495 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7571 | 0.060 |
Why?
|
Mice | 5 | 2024 | 81326 | 0.060 |
Why?
|
Phenotype | 2 | 2016 | 16575 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8530 | 0.060 |
Why?
|
Actins | 2 | 2010 | 2046 | 0.060 |
Why?
|
Telophase | 1 | 2003 | 7 | 0.060 |
Why?
|
Chromosome Segregation | 2 | 2018 | 234 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 456 | 0.060 |
Why?
|
Genome | 2 | 2009 | 1738 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2008 | 1169 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2006 | 444 | 0.050 |
Why?
|
Microinjections | 1 | 2003 | 321 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2006 | 540 | 0.050 |
Why?
|
PC12 Cells | 1 | 2002 | 317 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2002 | 237 | 0.050 |
Why?
|
Humans | 13 | 2023 | 761208 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9566 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1240 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 426 | 0.040 |
Why?
|
Cell Size | 1 | 2002 | 625 | 0.040 |
Why?
|
Genomics | 1 | 2016 | 5828 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13511 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3702 | 0.040 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12099 | 0.040 |
Why?
|
Models, Biological | 3 | 2020 | 9457 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1347 | 0.040 |
Why?
|
Nucleosomes | 1 | 2002 | 486 | 0.040 |
Why?
|
Nuclear Pore | 1 | 2018 | 62 | 0.040 |
Why?
|
Models, Molecular | 2 | 2010 | 5406 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 328 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 112 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4167 | 0.040 |
Why?
|
Cell Count | 1 | 2002 | 1831 | 0.040 |
Why?
|
Clone Cells | 1 | 2020 | 1668 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 671 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2018 | 442 | 0.030 |
Why?
|
Protein Transport | 2 | 2014 | 1958 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29687 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1743 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 902 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15545 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9297 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5662 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 4420 | 0.030 |
Why?
|
G1 Phase | 1 | 2014 | 404 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1730 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20982 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4111 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2010 | 370 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2010 | 249 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2522 | 0.020 |
Why?
|
Kinetochores | 1 | 2010 | 179 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4243 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2872 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2003 | 18926 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2974 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 751 | 0.020 |
Why?
|
Mutation | 2 | 2020 | 30002 | 0.020 |
Why?
|
Female | 5 | 2020 | 392544 | 0.020 |
Why?
|
Rats | 1 | 2002 | 23704 | 0.020 |
Why?
|
Oocytes | 1 | 2010 | 1165 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22127 | 0.020 |
Why?
|
DNA | 1 | 2018 | 7189 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10422 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1967 | 0.010 |
Why?
|
Inflammation | 1 | 2024 | 10759 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13402 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17598 | 0.010 |
Why?
|
Tubulin | 1 | 2004 | 692 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2426 | 0.010 |
Why?
|
Prophase | 1 | 2000 | 16 | 0.010 |
Why?
|
Blastoderm | 1 | 2000 | 28 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14392 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64681 | 0.010 |
Why?
|
Male | 2 | 2024 | 360693 | 0.000 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_